Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
NS Raje, E Anaissie, SK Kumar, S Lonial… - The Lancet …, 2022 - thelancet.com
Infection remains the leading cause of morbidity and mortality in patients with multiple
myeloma because of the cumulative effect of disease, treatment, and host-related factors …
myeloma because of the cumulative effect of disease, treatment, and host-related factors …
Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw
Japanese Allied Committee on Osteonecrosis of … - Journal of bone and …, 2017 - Springer
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is an intractable, though rare,
complication in cancer patients with bone metastases and patients with osteoporosis who …
complication in cancer patients with bone metastases and patients with osteoporosis who …
Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020
The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …
The dental management of patients at risk of medication‐related osteonecrosis of the jaw: new paradigm of primary prevention
Medication‐related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of
antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition …
antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition …
Workshop of european task force on medication related osteonecrosis of the jaw. Current challenges
This paper reports on the conclusions of two workshops held in Copenhagen in September
2017 and November 2018 focused on medication-related osteonecrosis of the jaws …
2017 and November 2018 focused on medication-related osteonecrosis of the jaws …
Time to onset of bisphosphonate‐related osteonecrosis of the jaws: a multicentre retrospective cohort study
Objectives Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of
bisphosphonates (BP). Although the risk of ONJ increases with increasing duration of BP …
bisphosphonates (BP). Although the risk of ONJ increases with increasing duration of BP …
Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive‐naïve patient: A comprehensive review of the literature
Objectives. To review the available literature on medication‐related osteonecrosis of the jaw
(MRONJ) associated with antiangiogenics in antiresorptive‐naïve individuals. Methods. A …
(MRONJ) associated with antiangiogenics in antiresorptive‐naïve individuals. Methods. A …
[HTML][HTML] Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug …
C Ottesen, M Schiodt, SS Jensen, T Kofod… - Oral Surgery, Oral …, 2022 - Elsevier
Objective. Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse
reaction to high-dose antiresorptive medication (AR) in patients with cancer. A temporary …
reaction to high-dose antiresorptive medication (AR) in patients with cancer. A temporary …
Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol
L Ramaglia, A Guida, V Iorio-Siciliano, A Cuozzo… - Clinical oral …, 2018 - Springer
Objective The most debated topic about medication-related osteonecrosis of the jaws
(MRONJ) is its therapy, as there are no definitive guidelines. The aims of this systematic …
(MRONJ) is its therapy, as there are no definitive guidelines. The aims of this systematic …
The treatment of medication-related osteonecrosis of the jaw (MRONJ): A systematic review with a pooled analysis of only surgery versus combined protocols
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of
antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating …
antiresorptive and antiangiogenic agents, and it is also a potentially painful and debilitating …